24 Dec Novacyt Trading Update
Novacyt trading update Paris, France and Camberley, UK – 24 December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics products, on the 11 December announced...
21 Dec Novacyt launches two new CE-IVD Marked molecular diagnostic kits
First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients Paris, France and Camberley, UK – 21 December 2018: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist...
21 Dec Novacyt launches two new CE-IVD Marked molecular diagnostic kits
Novacyt launches two new molecular CE Mark assays First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients...
11 Dec Novacyt announces update on strategic review of non-core assets
Novacyt announces update on strategic review of non-core assets NOVAprep® and clinical laboratory enter formal sales process Novacyt to enhance focus on core profitable diagnostic products business...
06 Dec Completion of substantial q16 molecular diagnostics order
Completion of substantial q16 molecular diagnostics order expands clinical diagnostic reach in fast growing Chinese market Paris, France and Camberley, UK – 6th December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM:...
06 Dec INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers https://novacyt.com/wp-content/uploads/2018/12/NOVACYT_CP_Droits-de-vote_2018-Dec.pdf ...
06 Dec Completion of substantial q16 molecular diagnostics order expands clinical diagnostic reach in fast growing Chinese market
Novacyt q16 order in China Paris, France and Camberley, UK – 6th December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces it has...
03 Dec Liquidity Agreement Monthly Update and Total Voting Rights
PParis, France and Camberley, UK – 3 December 2018 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares...
30 Nov The following announcement replaces the announcement released on 30 May 2018 at 18:30 (UK time) under RNS number 7508P.
Posted at 13:53h
in Novacyt Group
Replacement Announcement - Novacyt 30-11-18...
27 Nov NOVACYT SIGNS $3.0M DIAGNOSTICS SUPPLY AGREEMENT WITH GENESIS DIAGNOSTICS
PrimerDesign Genesis Diagnostics ENG Paris, France and Camberley, UK – 27th November 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing...